FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn’t target the brain like addictive opioids.

Please follow and like us:
error
fb-share-icon
Tweet
fb-share-icon

Trending now

Magnetic brain stimulation shows promise for tobacco addiction treatment
Mediterranean diet linked to reduced risk of cognitive decline in elderly women
Scientists observe lasting cognitive deficits in long COVID patients
People who believe conspiracy theories tend to report greater childhood adversity